Rishi Gupta
CIK 1537370 · last filed 2026-02-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$111.04M
Companies
5
Total Filings
21
Lifetime Open-Market Net
-$161.22M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMRA | Director | 7,663,349 | $14.49 | $111.04M | -$22.88M | 8 | 2026-02-17 |
| Turnstone Biologics Corp. (TSBX) Delisted | Director | 0 | $0.35 | $0 | $5.00M | 4 | 2025-08-08 |
| Verona Pharma plc (VRNA) Delisted | Director | 4,123,091 | $106.91 | $440.80M | -$145.94M | 5 | 2023-05-15 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | Director | 5,397,698 | — | — | $2.60M | 2 | 2016-05-23 |
| CCXI | Director | — | $14.52 | — | $0 | 1 | 2012-06-26 |
Recent Filings · Page 2 of 3
21 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-19 | IMRA | Exer (M) | +2,125 | $9.1K | EDGAR |
| 2023-05-15 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −482,913 | -$9.94M | EDGAR |
| 2023-04-28 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-06 | IMRA | Grant (A) | — | $0 | EDGAR |
| 2023-02-27 | IMRA | Grant (A) | +7,899,572 | $0 | EDGAR |
| 2022-12-27 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −6,139,864 | -$136.00M | EDGAR |
| 2022-04-29 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-10 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-23 | Dimension Therapeutics, Inc. (DMTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-10-29 | Dimension Therapeutics, Inc. (DMTX) Delisted | Mixed | +5,397,698 | $2.60M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.